BMEZ vs. HELX
Compare and contrast key facts about BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX).
HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BMEZ or HELX.
Key characteristics
| BMEZ | HELX | |
|---|---|---|
| YTD Return | 18.66% | 3.48% |
| 1Y Return | 31.75% | 20.90% |
| 3Y Return (Ann) | -7.84% | -14.60% |
| Sharpe Ratio | 2.02 | 1.06 |
| Sortino Ratio | 2.79 | 1.58 |
| Omega Ratio | 1.35 | 1.19 |
| Calmar Ratio | 0.65 | 0.33 |
| Martin Ratio | 7.38 | 4.36 |
| Ulcer Index | 3.90% | 4.20% |
| Daily Std Dev | 14.23% | 17.31% |
| Max Drawdown | -46.05% | -56.33% |
| Current Drawdown | -26.60% | -45.72% |
Correlation
The correlation between BMEZ and HELX is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BMEZ vs. HELX - Performance Comparison
In the year-to-date period, BMEZ achieves a 18.66% return, which is significantly higher than HELX's 3.48% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BMEZ vs. HELX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BMEZ vs. HELX - Dividend Comparison
BMEZ's dividend yield for the trailing twelve months is around 9.52%, while HELX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
BMEZ BlackRock Health Sciences Trust II | 9.52% | 10.81% | 11.28% | 6.75% | 3.14% |
HELX Franklin Genomic Advancements ETF | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% |
Drawdowns
BMEZ vs. HELX - Drawdown Comparison
The maximum BMEZ drawdown since its inception was -46.05%, smaller than the maximum HELX drawdown of -56.33%. Use the drawdown chart below to compare losses from any high point for BMEZ and HELX. For additional features, visit the drawdowns tool.
Volatility
BMEZ vs. HELX - Volatility Comparison
The current volatility for BlackRock Health Sciences Trust II (BMEZ) is 3.49%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 4.46%. This indicates that BMEZ experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.